Patients in England are set to receive some new medicines 3 to 6 months earlier under a streamlined approval process being launched by the MHRA and NICE.
A new treatment option for menopausal hot flushes and night sweats can be used in the NHS when hormone replacement therapy (HRT) is not suitable.
Ahead of Rare Disease Day on 28 February, we've published our first ever quality standard on rare diseases, and the first to have been developed in partnership with an external organisation.
A new type of tablet specifically designed to prevent migraine is transforming lives across England, with the number of people being prescribed these medicines more than tripling in just one year.
Hear from Ammaarah as she explains the remarkable impact hybrid closed loop technology has had on her life and how its successful rollout is the model we want to replicate.
Read our explainer on biosimilars and generics and the potential benefits they can offer.
Learn how NICE's healthtech guidance helped bring life-changing genetic testing to neonatal units across the UK, saving 20 babies' hearing so far with potential to prevent hearing loss in 200 babies annually.
How a collaborative taskforce is helping increase the uptake of biosimilars within the health and care sector.
